Data as of May 24
| +0.02 / +0.15%|
The 1 analysts offering 12-month price forecasts for Palomar Medical Technologies Inc have a median target of 14.50, with a high estimate of 14.50 and a low estimate of 14.50. The median estimate represents a +6.62% increase from the last price of 13.60.
The current consensus among 2 polled investment analysts is to Hold stock in Palomar Medical Technologies Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.